DR. VERNON D ROWE, MD
Neurology at Marshall Dr, Shawnee Mission, KS
License number
Kansas 04-17658
Category
Neurology
Type
Neurology
License number
Kansas R1C16
Category
Neurology
Type
Neurology
Address
Address
8550 Marshall Dr STE 100, Shawnee Mission, KS 66214
Phone
(913) 894-1500
(913) 894-1502 (Fax)
(913) 894-1502 (Fax)
Personal information
See more information about VERNON D ROWE at radaris.comName
Address
Phone
1800 Rocky Ford Cir, Manhattan, KS 66502
10 Cambridge Circle Dr, Kansas City, KS 66103
6415 Hillside St, Shawnee, KS 66218
8550 Marshall Dr, Overland Park, KS 66214
Organization information
See more information about VERNON D ROWE at bizstanding.comRowe Neurology Institute
Shawnee Mission, KS - Overland Park, KS
Status:
Inactive
Industry:
Medical Practice, Medical Doctor's Office, Medical Doctor's Office Medical Laboratory Health Practitioner's Office
Doing business as:
Consultants In Neurology, PA<br>Midamrica Nuroscience Institue<br>Rowe Neurology Institute<br>Vernon D Rowe, MD
Registration:
Aug 16, 2012
Inactive since:
Aug 16, 2017
Site:
Description:
Rowe Neurology Institute integrates a clinical practice, Consultants in Neurology, with an accredited MRI Imaging Center, an accredited 8 bed Sleep Center, Physical Therapy, and the MidAmerica Neurosc...
Addresses:
8550 Marshall Dr SUITE 100, Lenexa, KS 66214
8550 Marshall Dr SUITE 100, Overland Park, KS 66214 (Physical)
8550 Marshall Dr SUITE 100, Overland Park, KS 66214 (Physical)
State ID:
X01249523
Business type:
Fictitious Name
Medical Doctors:
Rachel Williams (Neurology),Maria A. Helms (Administrative Assistant),Kenneth R. Van Owen (Neurology),...
Specialties:
Headache, Sleep Disorders, Multiple Sclerosis, ...
Company size:
11-50 employees
Professional information
See more information about VERNON D ROWE at trustoria.com
Compositions Useful For Reducing Toxicity Associated With Gadolinium-Based Contrast Agents
Compositions Useful For Reducing Toxicity Associated With Gadolinium-Based Contrast Agents
US Patent:
8192721, Jun 5, 2012
Filed:
Dec 11, 2008
Appl. No.:
12/333168
Inventors:
Vernon D. Rowe - Shawnee KS, US
Assignee:
Verrow Pharmaceuticals, Inc. - Lenexa KS
International Classification:
A61B 5/055
US Classification:
424 932, 424 93, 424 9322
Abstract:
The invention relates to compositions comprising a gadolinium-based contrast agent and a derivatized cyclodextrin. Further provided are methods for reducing the toxicity associated with gadolinium-based contrast agents.
Compositions Useful For Reducing Nephrotoxicity And Methods Of Use Thereof
Compositions Useful For Reducing Nephrotoxicity And Methods Of Use Thereof
US Patent:
7658913, Feb 9, 2010
Filed:
May 25, 2007
Appl. No.:
11/753883
Inventors:
Vernon D. Rowe - Shawnee KS, US
Assignee:
Verrow Pharmaceuticals, Inc. - Lenexa KS
International Classification:
A61K 49/04
US Classification:
424 943, 424 94
Abstract:
The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs. The invention provides compositions comprising a substituted cyclodextrin, a nephrotoxic drug and a pharmaceutically acceptable carrier, where the cyclodextrin is present in an amount effective for substantially inhibiting the nephrotoxic effect of the drug.
Compositions Useful For Reducing Nephrotoxicity And Methods Of Use Thereof
Compositions Useful For Reducing Nephrotoxicity And Methods Of Use Thereof
US Patent:
8277779, Oct 2, 2012
Filed:
Dec 18, 2009
Appl. No.:
12/641708
Inventors:
Vernon D. Rowe - Shawnee KS, US
International Classification:
A61K 49/04
US Classification:
424 943, 424 94
Abstract:
The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs. The invention provides compositions comprising an anionically substituted cyclodextrin, a nephrotoxic drug and a pharmaceutically acceptable carrier, where the cyclodextrin is present in an amount effective for substantially inhibiting the nephrotoxic effect of the drug.
Methods For Reducing Cisplatin Nephrotoxicity
Methods For Reducing Cisplatin Nephrotoxicity
US Patent:
2011002, Feb 3, 2011
Filed:
Oct 13, 2010
Appl. No.:
12/903934
Inventors:
Vernon D. Rowe - Shawnee KS, US
Assignee:
VERROW PHARMACEUTICALS, INC. - Lenexa KS
International Classification:
A61K 33/24, A61P 35/00
US Classification:
424649
Abstract:
The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs such as cisplatin. The invention provides compositions comprising a substituted cyclodextrin, cisplatin and a pharmaceutically acceptable carrier, where the cyclodextrin is present in an amount effective for substantially inhibiting the nephrotoxic effect of the cisplatin.
Methods Of Reducing Methotrexate Nephrotoxicity
Methods Of Reducing Methotrexate Nephrotoxicity
US Patent:
2011002, Feb 3, 2011
Filed:
Oct 13, 2010
Appl. No.:
12/903950
Inventors:
Vernon D. Rowe - Shawnee KS, US
Assignee:
VERROW PHARMACEUTICALS, INC. - Lenexa KS
International Classification:
A61K 31/7028, A61K 31/724, A61P 13/12
US Classification:
514 25, 514 58
Abstract:
The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs such as methotrexate. The invention provides compositions comprising a substituted cyclodextrin, methotrexate and a pharmaceutically acceptable carrier, where the cyclodextrin is present in an amount effective for substantially inhibiting the nephrotoxic effect of the methotrexate.
Compositions Useful For Reducing Nephrotoxicity And Methods Of Use Thereof
Compositions Useful For Reducing Nephrotoxicity And Methods Of Use Thereof
US Patent:
2007012, May 31, 2007
Filed:
Nov 22, 2006
Appl. No.:
11/562924
Inventors:
Vernon Rowe - Shawnee KS, US
International Classification:
A61K 31/724, A61K 31/704
US Classification:
514034000, 514058000
Abstract:
The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs. The invention provides compositions comprising an anionically substituted oligosaccharide, a nephrotoxic drug and a pharmaceutically acceptable carrier, where the oligosaccharide is present in an amount effective for substantially inhibiting the nephrotoxic effect of the drug.
Compositions Useful For Reducing Nephrotoxicity And Methods Of Use Thereof
Compositions Useful For Reducing Nephrotoxicity And Methods Of Use Thereof
US Patent:
8574551, Nov 5, 2013
Filed:
Aug 23, 2012
Appl. No.:
13/592510
Inventors:
Vernon D. Rowe - Shawnee KS, US
Assignee:
Verrow Pharmaceuticals, Inc. - Lenexa KS
International Classification:
A61K 49/04
US Classification:
424 943, 424 94
Abstract:
The present invention provides compositions and methods to reduce renal damage caused by nephrotoxic drugs. The invention provides compositions comprising an anionically substituted cyclodextrin, a nephrotoxic drug and a pharmaceutically acceptable carrier, where the cyclodextrin is present in an amount effective for substantially inhibiting the nephrotoxic effect of the drug.